C7A.01
Malignant carcinoid tumors of the small intestine
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant carcinoid tumors of the small intestine are a rare type of neuroendocrine tumor that originates in the cells of the small intestine. These tumors develop from neuroendocrine cells, which are responsible for releasing hormones into the bloodstream. Though they are classified as cancerous, carcinoid tumors often grow slowly and may not cause immediate symptoms. Understanding this condition is vital for early diagnosis and appropriate management.
Causes & Symptoms
Clinical Causes: Genetic predisposition or family history of neuroendocrine tumors Certain inherited syndromes such as Multiple Endocrine Neoplasia type 1 (MEN1) Chronic inflammatory conditions affecting the small intestine Previous radiation exposure to the abdomen Age-related factors, more common in middle-aged and older adults
Key Symptoms: Abdominal pain or discomfort Changes in bowel habits, such as diarrhea or constipation Unexplained weight loss Feeling of fullness or bloating after eating Nausea and vomiting Carcinoid syndrome symptoms, including flushing, sweating, and wheezing (when the tumor metastasizes to the liver producing hormone-like substances)
Diagnostic & Treatment
Diagnosis Path: Blood and urine tests to detect elevated levels of serotonin and other tumor markers Imaging studies such as CT scans, MRI, and octreotide scans to locate the tumor Endoscopy or capsule endoscopy to visualize the small intestine directly Biopsy of the tumor tissue for histopathological examination Assessment of metastatic spread, especially to the liver
Treatment Protocols: Surgical resection of the primary tumor and affected lymph nodes Medications such as somatostatin analogs (e.g., octreotide) to control symptoms and slow tumor growth Targeted therapies, including peptide receptor radionuclide therapy (PRRT), for advanced or metastatic disease Chemotherapy and radiation therapy, although these are less commonly effective for carcinoid tumors Management of carcinoid syndrome symptoms with medications and supportive care
Clinical Advice & FAQs
Billing Guidance
Is C7A.01 a billable ICD-10 code?
Yes, C7A.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C7A.01?
Clinical documentation must specify the nature of Malignant carcinoid tumors of the small intestine and any associated comorbidities for accurate reporting.
Cite this Clinical Reference